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Abstract
β-lactam antibiotics (i.e. penicillin) are crucial to the field of medicine. Yet due to the
reliance and over-prescription of these antibiotics, bacteria become resistant to many drugs that
were once extremely efficient. Many resistant bacteria express an enzyme, known as a βlactamase, which hydrolyzes the amide bond of the defining four membered β-lactam ring,
rendering the drug inactive. The carbapenem-hydrolyzing class D -lactamases (CHDLs), are a
particularly worrisome subtype of the class D enzymes. OXA-24 is a clinically relevant member
of the CHDLs and, therefore, is a key target to inhibit. Atomic structures of OXA-24 in
complexes with β-lactam ligands would inform inhibitor design efforts. Currently OXA-24 is
crystallized using high concentrations of ammonium sulfate (2.0 M), resulting in the presence of
a sulfate ion in the active site of the enzyme, preventing certain ligands from binding. In order to
discover an inhibitor for OXA-24, a complex without the ammonium sulfate in the active site
must be found. In this experiment, we show that the lowest concentration that still allows for
crystallization of OXA-24 is 1.4 M ammonium sulfate. We also discovered a novel
crystallization condition for OXA-24 with a significantly lower concentration of sulfate (0.2 M
lithium sulfate). Optimizing this new condition may aid in future crystallization efforts and
eventual inhibitor discovery.

Introduction
Since the discovery of the penicillin by Alexander Fleming in 1928, antibiotics have
revolutionized the medical world. Penicillin belongs to a large class of antibiotics which fall
under the structurally derived name of -lactams. These drugs are characterized by their fourmembered -lactam ring (a cyclic amide). Each -lactam is distinguished by differing, unique
side chains, known as R1 and R2 (Patrick, 2005). Several classes of -lactam antibiotics exist:
penicillins, cephalosporins, carbapenems, and monobactams (shown in Figure 1).
-lactam antibiotics are the most widely used class of antibiotics because they
successfully fight most bacterial infections by inhibiting cell wall synthesis. Their mechanism of
action is to bind to and inhibit transpeptidase enzymes, located in the bacterial cell membrane.
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This enzyme is often referred to as a penicillin-binding
protein (PBP) and is responsible for cross-linking the
bacterial cell wall. -lactams mimic the structure of the
usual PBP substrate and therefore disrupt the crosslinking, critical to cell wall synthesis. Once the -lactam
ring is bound to the PBP, the enzyme is irreversibly
inactivated. As a result, the bacterial cell wall is
compromised, and the bacteria lyse and die (Patrick,

Figure 1. Structure of several common classes of lactam antibiotics. The -lactam ring is highlighted
in blue.

2005).
-lactam antibiotics can be highly effective, especially since they target an enzyme found
exclusively in bacteria. However, due to their overprescription and misuse, bacterial resistance
has developed. Much of this resistance is due to the expression of -lactamase enzymes by the
bacteria. -lactamases act by cleaving the -lactam ring and render the antibiotic inactive before
it has a chance to inhibit the transpeptidase enzymes (Neu, 1992). The growing threat of
resistance has initiated the search for both novel antibiotics that are not destroyed by lactamases and also -lactamase inhibitors.
-lactamases are grouped into four different classes: A, B, C and D. The class D lactamases, or OXAs, are not inhibited by current clinical -lactamase inhibitors, such as
clavulanic acid. Even more concerning is a subgroup of the class D enzymes known as the
carbapenem-hydrolyzing class D -lactamases (CHDLs), of which OXA-24 is a representative
member. This aggressive-lactamase can destroy the newer carbapenem antibiotics and,
therefore, is key to inhibit.
In order to assist with the development of inhibitors for these -lactamases, their
chemical properties and three dimensional structure must be better understood. OXA-24 has
been successfully expressed, purified, and crystallized. In addition, the three-dimensional
structure has been determined by X-ray crystallography, however, contains a sulfate ion in the
active site where a -lactam or inhibitor would be expected to bind. We hypothesize that the
presence of this sulfate ion in the OXA-24 active site may prevent the binding of certain
molecules for which we would like to obtain complexes with OXA-24. The current
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crystallization conditions for OXA-24 contain a high concentration of ammonium sulfate (2.0
M). In this study, we seek to reduce the concentration of ammonium sulfate required to
crystallize OXA-24 with the hope of removing the sulfate ion from the active site. In order to
determine the lowest concentration of ammonium sulfate which OXA-24 would crystallize in,
the ammonium sulfate was titrated out of the known crystallization buffer and new conditions
which greatly lower or eliminate the ammonium sulfate were tested.
We found that OXA-24 does in fact crystallize at lower concentrations of ammonium
sulfate (1.4 M), yet the crystals are small, diffract to low resolution, and ultimately the structures
determined from crystals grown in 1.4 M ammonium sulfate showed that the sulfate ion
remained present in the active site. However we identified several new conditions that crystallize
OXA-24. One of these conditions also contains sulfate, but at a much lower concentration (0.2 M
lithium sulfate), and another does not contain ammonium sulfate at all. These conditions need to
be optimized for future crystallography studies.

Methods
WT OXA-24 Expression and Purification
BL21(DE3) Escherichia coli cells containing pET-24 plasmid with the wild-type OXA24 gene were grown in Luria broth supplemented with 25 mg/mL kanamycin overnight at 37⁰C.
The starter culture was used to inoculate 1 L Luria broth with 25 mg/mL kanamycin, shaking for
approximately two hours at 37⁰C until the OD600 reached ~0.6-0.8.
Protein expression was induced by the addition of isopropylthio-β-galactoside (IPTG) to
a final concentration of 100 M. After induction, the culture continued to shake at 37⁰C for two
hours until the OD600 was ~1.5. The culture was centrifuged a Sorval centrifuge using a SLA3000 rotor at 7500 rpm at room temperature for 20 minutes. The resulting bacterial cell pellet
was frozen at -20⁰C to facilitate cell lysis.
The cell pellet was thawed and resuspended in 20 mL of 50 mM sodium phosphate, pH
7.0 and 1 mM ethylenediaminetetraacetic acid (EDTA). Then, 0.5 mg/mL lysozyme and 100 µM
of HALT protease inhibitor cocktail (Pierce) were added and incubated at room temperature.
When the viscosity of the resuspended cells had greatly increased, 5 mM DNase I and 5 mM
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magnesium chloride were added. When the viscosity was eliminated, the solution was
centrifuged using the SS-34 rotor at 15000 rpm at 4⁰C for 30 minutes to rid the protein of
contaminating material, such as organelles and cell wall fragments. The lysate was transferred,
without disturbing the pellet, to 10 kDa MWCO dialysis tubing (Sigma), previously clipped and
rinsed. Both ends of the dialysis tubing containing the lysate were clamped and dialyzed against
5 L of 5 mM sodium phosphate, pH 5.8, over night with stirring at 4⁰C.
In order to purify OXA-24, a 1.5 x 10 cm column of carboxy-methyl cellulose (CM-23,
Sigma) was prepared and equilibrated with 5 mM sodium phosphate, pH 5.8 buffer. The dialyzed
solution was eluted through the column and washed with 5 mM sodium phosphate, pH 5.8
buffer. In order to elute the OXA-24 bound to the column, a linear gradient of 5 mM sodium
phosphate, pH 5.8 to 50 mM sodium phosphate, pH 7.0 was used (approximately 75 mL of each
buffer). Fractions of 8 mL were collected and tested using Bradford dye to determine the
fractions with the highest concentrations of protein (Bradford, 1976). A kinetics assay using
cephalothin nitrothiobenzoic acid (CENTA) was also performed on fractions containing the
highest protein concentrations to confirm the presence of -lactamase activity. In addition, a
sample of each peak fraction was electrophoresed for 30 minutes at 200 V on a 10% SDS-PAGE
gel to test for purity of the protein. The most pure OXA-24 containing fractions were
concentrated in an Amicon Ultra 10 kDa MWCO spin concentrator (Millipore). The A280 was
measured, and the final OXA-24 concentration was calculated to be 13.3 mg/mL.

Crystallization
OXA-24 was previously crystallized using Hampton Research Screen I Reagent #4 (100
mM Tris HCl, pH 8.5, 2.0 M ammonium sulfate). Seven buffers were prepared by titrating the
ammonium sulfate to concentrations of 2.0 M, 1.7 M, 1.4 M, 1.0 M, 0.7 M, 0.3 M, and 0.0 M
ammonium sulfate, while the 100 mM Tris HCl, pH 8.5 buffer remained constant. A stock of
concentrated OXA-24 (13.3 mg/mL) was crystallized at 25⁰C by vapor diffusion in hanging
drops equilibrated over 500 L of 100 mM Tris HCl, pH 8.5 and varying ammonium sulfate
concentrations. A ratio of 3:1 (protein:buffer) was used for a final protein concentration of 10
mg/mL in the drop. In addition to optimizing previous crystallization conditions, an attempt to
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identify novel crystallization conditions using the JCSG-plus screen was made. Conditions 1-24
were tested in 1:1 and 5:3 ratios (protein:buffer) using hanging drop diffusion at 25⁰C.

Data Collection
Crystals grown in 1.4 M ammonium sulfate and 1.7 M ammonium sulfate were looped
and frozen in liquid nitrogen after the appropriate soaks in cryoprotectant composed of 5%
sucrose, 25 mM sodium bicarbonate, 30 mM of the drug (ceftazidime, cefotaxime, cefoxitin),
and well buffer. After soaking in the cryoprotectant for approximately ten minutes, the crystals
were re-looped and flash frozen in liquid nitrogen for transportation to Argonne National
Laboratories in a travel dewar filled with liquid nitrogen. The LS-CAT beamline, sector 21, was
used to determine diffraction patterns and collect data sets. Data sets were taken for one single
crystal at a time.

Results
OXA-24 expression and purification
OXA-24 was expressed and purified to a final yield of 20 mg per 1 L culture, as
determined by measuring the absorbance of the final protein solution at 280 nm. Protein samples
were collected throughout the course of the experiment and were electrophoresed using a 10%
SDS-PAGE gel (Fig. 2, A). Lane 2 shows the time point immediately before induction with
IPTG. Within 30 minutes after induction, a significant band emerges and gradually gets darker
over time (lanes 3-5) denoting expression of a protein of approximately 27,000 Daltons – the
molecular weight of OXA-24. An SDS-PAGE gel was also performed on the collected fractions
of purified protein. The fractions were electrophoresed for 30 minutes and a single band
appeared denoting the prescense of pure protein.
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Figure 2. A) SDS-PAGE gel analysis of OXA-24 expression in Escherichia coli. OXA-24 has a molecular weight of around 27 kDa. A 2 L flask
supplemented with 25 mg/mL kanamycin was inoculated with an overnight culture of BL21(DE3) Escherichia coli. Once the bacterial growth reached an
OD600 between 0.6-0.8, the culture was induced with 100 M IPTG. The gel shows samples that were collected before and after induction with IPTG as
well as the protein present after dialysis and elution through the CM-cellulose column. The band darkens in lanes 3-5 denoting protein transcription and
growth due to IPTG induction. B) SDS-PAGE gel analysis of OXA-24 purification. Dialyzed lysate was eluted through a CM-cellulose column and
collected into 8 mL fractions. The gel shows samples of fractions 13-18. The clear single band denotes pure OXA-24.

Kinetics
To confirm that the protein expressed and purified was indeed OXA-24, an assay that
measured -lactamase activity was performed. The amount of active -lactamase in collected
protein fractions was measured spectrophotometrically using a colorimetric assay. Cephalothin
nitrothiobenzoic acid (CENTA) was used as the substrate to determine -lactamase activity
(0.075 mM CENTA). If -lactamase is present, the -lactam ring of CENTA is hydrolyzed
causing the release of thionitrobenzoic acid (TNBA). TNBA is a dark yellow color at pH 7,
allowing the rate of product formation to be monitored spectrophotometrically at a wavelength of
405 nm. The rate of -lactamase activity is plotted vs. the chromatography fraction number
(Figure 3). The fraction with the most activity was fraction 14 with a rate of 0.2115/s. Fractions
13-20 also contained significant activity and were pooled together and concentrated for
crystallization experiments.
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Figure 3. Colorimetric kinetics assay of OXA-24 WT activity with CENTA. Ten of the collected protein fractions were tested for -lactamase
activity against a -lactam containing substrate, CENTA. The rate of activity, in turnovers per second, was plotted vs. the fraction number to
identify the peak of -lactamase activity.

Crystallization
Current crystallization conditions for OXA-24 contain a high concentration of
ammonium sulfate (2.0 M). This results in the presence of a sulfate ion in the active site of the
enzyme, preventing certain ligands from binding and preventing the determination of a structure
of the enzyme in complex with the ligand of interest. In an effort to displace the sulfate ion from
the active site of OXA-24, crystallization was attempted by lowering the concentration of
ammonium sulfate. Seven solutions of 100 mM Tris HCl, pH 8.5 with decreasing concentrations
of ammonium sulfate (1.7 M, 1.4 M, 1.0 M, 0.7 M, 0.3 M, and 0.0 M ammonium sulfate) were
prepared for use in crystallization of OXA-24. Extremely small, OXA-24 crystals were found in
100 mM Tris HCl, pH 8.5 buffers with concentrations of 1.7 M and 1.4 M ammonium sulfate
(Figure 4, B). The previous condition containing 2.0 M ammonium sulfate, produced large, long
crystals of OXA-24 (Figure 4, A).

A

B

Figure 4. OXA-24 WT crystals grown by hanging drop diffusion at room temperature. A: OXA-24 grown under the
known crystallization conditions of 100 mM Tris HCl, pH 8.5 and 2.0 M ammonium sulfate. B: OXA-24 crystals grown
with 100 mM Tris HCl, pH 8.5 and 1.4 M ammonium sulfate. A distinctive size difference is observed at lowered
concentrations of ammonium sulfate.
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JCSG Screen
To identify novel crystallization conditions, a JCSG-plus screen testing reagents 1-24
(listed in Table 1) was set up using 8 mg/mL OXA-24 mixed 1:1 and 5:3 (protein:buffer) with
screening reagent. Many conditions showed precipitation of protein and are not suitable for
crystal growth of OXA-24 (Figure 5, wells 1, 5, 7, 9, 12, 15, 17, 18, 20, 21, 23, and 24) However
the screen also yielded many sites of crystallization. Several drops showed what appeared to be
the start of very small OXA-24 crystals (Figure 5, wells 2, 6, 10, 14, and 16). The buffers
producing these crystals all shared a common reagent: polyethylene glycol (PEG). Well 6
produced feathery-like crystals which were determined to be protein at Argonne National Lab.
Several drops contained one single crystal (4, 5, and 20) but were determined to be salt at
Argonne. Additional conditions containing small crystals (2, 10, 14, and 16) may benefit from
optimization.

Figure 5. JCSG-plus screen set up with OXA-24 WT. Buffer 6 (20% w/v PEG 1000, 0.1 M phosphate/citrate, pH 4.2 and 0.2 M lithium
sulfate) produced feathery, long crystals which were determined to be protein. Several other drops appeared to show sites of nucleation (2,
10, 14, and 16) and three drops yielded a single salt crystal but no protein crystal.
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Reagent #

Conditions

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

50% v/v PEG 400, 0.1 M sodium acetate pH 4.5, 0.2 M lithium sulfate
20% w/v PEG 3000, 0.1 M sodium citrate pH 5.5
20 % w/v PEG 3350, 0.2 di-ammonium hydrogen citrate
30% v/v MPD, 0.1 M sodium acetate ph 4.6, 0.02 M calcium chloride
20% w/v PEG 3350, 0.2 M magnesium formate
20% w/v PEG 1000, 0.1 M phosphate/citrate pH 4.2, 0.2 M lithium sulfate
20% w/v PEG 8000, 0.1 M CHES pH 9.5
20% w/v PEG 3350, 0.2 M ammonium formate
20% w/v PEG 3350, 0.2 M ammonium chloride
20% w/v PEG 3350, 0.2 M potassium formate
50% v/v MPD, 0.1 M Tris pH 8.5, 0.2 M ammonium dihydrogen phosphate
20% w/v PEG 3350, 0.2 M potassium nitrate
0.8 M ammonium sulfate, 0.1 M citrate pH 4.0
20% w/v PEG 3350, 0.2 M sodium thiocyanate
20% w/v PEG 6000, 0.1 M bicine pH 9.0
10% w/v PEG 8000, 8% v/v ethylene glycol, 0.1 M HEPES pH 7.5
40% v/v MPD, 5% w/v PEG 8000, 0.1 M sodium cacodylate pH 6.5
40% v/v ethanol, 5% w/v PEG 1000, 0.1 M phosphate/citrate pH 4.2
8% w/v PEG 4000, 0.1 M sodium acetate pH 4.6
10% w/v PEG 8000, 0.1 M Tris pH 7.0, 0.2 M magnesium chloride
20% w/v PEG 6000, 0.1 M citrate pH 5.0
50% v/v PEG 200, 0.1 M sodium cacodylate pH 6.5, 0.2 M magnesium chloride
1.6 M sodium citrate pH 6.5
20% w/v PEG 3350, 0.2 M potassium citrate

Crystal Growth?
N
Y
Y
salt crystal
salt crystal
Y-confirmed protein
N
N
N
Y
drop dried out
N
N
Y
N
Y
N
N
N
salt crystal
N
drop dried out
N
N

Table 1. JCSG-plus screen reagent conditions. A screen was performed using conditions 1-24. Possible sites of OXA-24
crystal growth were observed in reagents 2, 6, 10, 14, 16. Reagents 4, 5, and 20 yielded a salt crystal but no protein crystal.
Reagent 6 produced OXA-24 crystals, confirmed at Argonne National Laboratories.

Discussion
OXA-24 WT expression and purification
The expression of OXA-24 WT in BL21(DE3) Escherichia coli was successful. We
obtained a yield of 20 mg/L. The SDS-PAGE gel (Figure 2, A) performed on collected samples
of the bacterial culture shows successful induction with IPTG. The two hour induction period
was sufficient for expression and the previously reported methods of purification (ion-exchange
chromatography) were successful, as seen in the SDS-PAGE gel of purified fractions of OXA-24
(Figure 2, B).
Kinetics assay with CENTA
The colorimetric assay performed with CENTA allowed for determination of -lactamase
activity following chromotograpy. The rate of hydrolysis of CENTA was maximal in fraction 14
(Figure 3). -lactamase readily binds to the substrate, CENTA, breaking the -lactam ring and
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turning it into cephalosproanic acid core and thionitrobenzoic acid (TNBA) producing a dark
yellow color at pH of 7. Therefore, the darker the yellow, the more CENTA which was turned
over and the more -lactamase present.
Crystallization
OXA-24 crystallized well using Hampton Research Screen I Reagent #4 (100 mM Tris
HCl, pH 8.5, 2.0 M ammonium sulfate). Crystals seemed to grow the best using a 5:3 or 6:2 ratio
of protein to buffer, producing a final protein concentration of 8-10 mg/mL in the drop, and 1
mL of buffer in the well. Crystal growth of OXA-24 was also observed using these same protein
ratios, but at lower concentrations of ammonium sulfate within the buffer (1.7 M and 1.4 M).
These crystals were very small and clustered together, especially in the 1.7 M concentration.
Data Collection
The OXA-24 crystals diffracted but only to low resolution which could be attributed to
the extremely small size of the crystals due to the altered crystallization conditions. Data sets
were collected for a crystal grown in the 1.7 M ammonium sulfate condition and soaked in
ceftazidime. We determined that ceftazidime was not bound, and even at the reduced ammonium
sulfate concentration the sulfate ion was still present in the active site.
We had some encouraging results from crystals obtained in the JCSG-plus screen.
Several crystals from the same condition proved to be protein and produced diffraction patterns
when subjected to the X-ray beam. These crystals had been grown in Reagent #6 from the JCSG
screen (20% w/v PEG 1000, 0.1 M phosphate/citrate, pH 4.2 and 0.2 M lithium sulfate). Though
the buffer still contains sulfate, it is a much lower concentration than that of the ammonium
sulfate used in the known condition. This positive result provides a different condition in which
OXA-24 crystallizes which may be optimized for further crystallization and eventual enzyme
inhibition.
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Conclusion and Future Directions
Although the sulfate ion is still present in the active site of OXA-24 crystals obtained
with lowered concentrations of ammonium sulfate (1.4 M and 1.7 M), a novel condition (0.2 M
LiSO4) has been discovered which could benefit from optimization. With the optimization of this
new condition from the JCSG-plus screen, we may be able to obtain a structure of OXA-24
without a sulfate ion. This would allow us to capture complexes of OXA-24 bound with other
ligands that cannot be obtained when the sulfate ion is bound. These structures will aid in the
future research and discovery of a novel inhibitor for the class D lactamase, OXA-24.
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